SelectQuote (SLQT)
Market Price (2/18/2026): $0.8435 | Market Cap: $158.2 MilSector: Financials | Industry: Insurance Brokers
SelectQuote (SLQT)
Market Price (2/18/2026): $0.8435Market Cap: $158.2 MilSector: FinancialsIndustry: Insurance Brokers
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 49%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 45% | Weak multi-year price returns2Y Excs Rtn is -83%, 3Y Excs Rtn is -127% | Penny stockMkt Price is 0.8 |
| Valuation becoming less expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -58% | Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 264% | |
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, E-commerce & Digital Retail, and Digital Health & Telemedicine. Themes include Geriatric Care, Show more. | Key risksSLQT key risks include [1] a U.S. Show more. |
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 49%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 45% |
| Valuation becoming less expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -58% |
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, E-commerce & Digital Retail, and Digital Health & Telemedicine. Themes include Geriatric Care, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -83%, 3Y Excs Rtn is -127% |
| Penny stockMkt Price is 0.8 |
| Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 264% |
| Key risksSLQT key risks include [1] a U.S. Show more. |
Qualitative Assessment
AI Analysis | Feedback
1. Lowered Fiscal Year 2026 Guidance Due to External Headwinds.
SelectQuote significantly reduced its fiscal year 2026 guidance, lowering its consolidated revenue range to $1.61 billion to $1.71 billion from a previous range of $1.65 billion to $1.75 billion, and adjusted EBITDA to $90 million to $100 million from $120 million to $150 million. This downward revision was primarily attributed to an explicit $40 million headwind, which included approximately $20 million from Pharmacy Benefit Manager (PBM) reimbursement changes and another $20 million from a national carrier's marketing budget cuts. This revised outlook led to a negative investor response, with the stock falling 6.83% in premarket trading on February 5, 2026, despite beating earnings per share expectations.
2. Significant Decline in Senior Segment Performance in Fiscal Q1 2026.
In its fiscal first-quarter 2026 earnings report on November 6, 2025, SelectQuote's Senior segment experienced a substantial 37% year-over-year revenue decline, dropping from $93 million to $59 million. This segment also shifted from a positive adjusted EBITDA to a negative $21 million. The company attributed this decline to changes in Special Enrollment Period (SEP) eligibility guidelines, which negatively impacted close rates and policy volume. This mixed financial picture, despite a consolidated revenue beat, triggered a sharp 15.21% drop in the company's share price following the earnings release.
Show more
Stock Movement Drivers
Fundamental Drivers
The -59.8% change in SLQT stock from 10/31/2025 to 2/17/2026 was primarily driven by a -74.9% change in the company's P/E Multiple.| (LTM values as of) | 10312025 | 2172026 | Change |
|---|---|---|---|
| Stock Price ($) | 2.08 | 0.84 | -59.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,527 | 1,619 | 6.1% |
| Net Income Margin (%) | 3.1% | 4.8% | 54.0% |
| P/E Multiple | 8.1 | 2.0 | -74.9% |
| Shares Outstanding (Mil) | 184 | 188 | -1.8% |
| Cumulative Contribution | -59.8% |
Market Drivers
10/31/2025 to 2/17/2026| Return | Correlation | |
|---|---|---|
| SLQT | -59.8% | |
| Market (SPY) | 0.1% | 33.4% |
| Sector (XLF) | -0.3% | 37.3% |
Fundamental Drivers
The -52.5% change in SLQT stock from 7/31/2025 to 2/17/2026 was primarily driven by a -97.6% change in the company's P/E Multiple.| (LTM values as of) | 7312025 | 2172026 | Change |
|---|---|---|---|
| Stock Price ($) | 1.76 | 0.84 | -52.5% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,489 | 1,619 | 8.8% |
| Net Income Margin (%) | 0.2% | 4.8% | 1834.0% |
| P/E Multiple | 84.9 | 2.0 | -97.6% |
| Shares Outstanding (Mil) | 178 | 188 | -5.0% |
| Cumulative Contribution | -52.5% |
Market Drivers
7/31/2025 to 2/17/2026| Return | Correlation | |
|---|---|---|
| SLQT | -52.5% | |
| Market (SPY) | 8.3% | 27.7% |
| Sector (XLF) | 0.0% | 30.1% |
Fundamental Drivers
The -80.6% change in SLQT stock from 1/31/2025 to 2/17/2026 was primarily driven by a -81.8% change in the company's P/S Multiple.| (LTM values as of) | 1312025 | 2172026 | Change |
|---|---|---|---|
| Stock Price ($) | 4.31 | 0.84 | -80.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,381 | 1,619 | 17.2% |
| P/S Multiple | 0.5 | 0.1 | -81.8% |
| Shares Outstanding (Mil) | 170 | 188 | -9.1% |
| Cumulative Contribution | -80.6% |
Market Drivers
1/31/2025 to 2/17/2026| Return | Correlation | |
|---|---|---|
| SLQT | -80.6% | |
| Market (SPY) | 14.5% | 27.0% |
| Sector (XLF) | 2.5% | 30.7% |
Fundamental Drivers
The -3.0% change in SLQT stock from 1/31/2023 to 2/17/2026 was primarily driven by a -47.5% change in the company's P/S Multiple.| (LTM values as of) | 1312023 | 2172026 | Change |
|---|---|---|---|
| Stock Price ($) | 0.86 | 0.84 | -3.0% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 770 | 1,619 | 110.2% |
| P/S Multiple | 0.2 | 0.1 | -47.5% |
| Shares Outstanding (Mil) | 165 | 188 | -12.1% |
| Cumulative Contribution | -3.0% |
Market Drivers
1/31/2023 to 2/17/2026| Return | Correlation | |
|---|---|---|
| SLQT | -3.0% | |
| Market (SPY) | 74.2% | 29.6% |
| Sector (XLF) | 49.3% | 31.7% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| SLQT Return | -56% | -93% | 104% | 172% | -62% | -37% | -96% |
| Peers Return | -67% | -63% | 15% | 78% | 1% | -28% | -82% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | -0% | 82% |
Monthly Win Rates [3] | |||||||
| SLQT Win Rate | 50% | 17% | 50% | 50% | 42% | 50% | |
| Peers Win Rate | 30% | 30% | 55% | 60% | 48% | 20% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 50% | |
Max Drawdowns [4] | |||||||
| SLQT Max Drawdown | -62% | -94% | -7% | -25% | -64% | -40% | |
| Peers Max Drawdown | -72% | -80% | -33% | -28% | -43% | -30% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -1% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: EHTH, GOCO, EVER, LMND, HIPO.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 2/17/2026 (YTD)
How Low Can It Go
| Event | SLQT | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -98.4% | -25.4% |
| % Gain to Breakeven | 6007.9% | 34.1% |
| Time to Breakeven | Not Fully Recovered days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -41.3% | -33.9% |
| % Gain to Breakeven | 70.3% | 51.3% |
| Time to Breakeven | 109 days | 148 days |
Compare to EHTH, GOCO, EVER, LMND, HIPO
In The Past
SelectQuote's stock fell -98.4% during the 2022 Inflation Shock from a high on 4/6/2021. A -98.4% loss requires a 6007.9% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About SelectQuote (SLQT)
AI Analysis | Feedback
- Senior Insurance: Connects seniors with Medicare Advantage, Medicare Supplement, and Prescription Drug Plans from various carriers.
- Life Insurance: Offers term life and whole life insurance policies to individuals and families from a diverse panel of insurance providers.
- Auto & Home Insurance: Provides quotes and policies for automobile and homeowners' insurance through multiple carriers.
AI Analysis | Feedback
```htmlSelectQuote (SLQT) primarily sells to **individuals**, acting as a direct-to-consumer insurance broker. It connects individual consumers with various insurance carriers.
The company serves the following categories of individual customers:
-
Seniors: This category includes individuals eligible for Medicare who are seeking Medicare Advantage, Medicare Supplement, or Prescription Drug Plans.
-
Life Insurance Seekers: This category comprises individuals looking for term life or whole life insurance policies to protect their families and assets.
-
Auto & Home Insurance Seekers: This category consists of individuals looking for property and casualty insurance products, such as auto insurance and homeowners or renters insurance.
AI Analysis | Feedback
- UnitedHealth Group (UNH)
- Humana Inc. (HUM)
- CVS Health Corporation (CVS)
- Elevance Health Inc. (ELV)
- Centene Corporation (CNC)
AI Analysis | Feedback
Timothy "Tim" Danker, Chief Executive Officer
Timothy "Tim" Danker has served as CEO of SelectQuote since 2017. He co-founded and served as Chief Executive Officer of Spring Venture Group, a direct-to-consumer insurance brokerage, from 2007 to 2012, before joining SelectQuote in 2010. Prior to his CEO role, he held various leadership positions within SelectQuote, including President of the Life division (2016-2019), Executive Vice President of the Life division (2015-2016), and President of the Auto & Home division (2012-2015). Danker has also held leadership roles at companies such as Cerner and Sprint.
Ryan Clement, Chief Financial Officer
Ryan Clement joined SelectQuote in January 2022 and was appointed Chief Financial Officer in February 2023, after serving as Interim CFO since May 2022. Before joining SelectQuote, he served as the Chief Financial Officer of Sifted (formerly VeriShip), a SaaS-based logistics software company. Clement also spent seven years at Edelman Financial Engines, a registered investment advisory firm, where he held various senior finance and operational roles. His career also includes roles at The Mutual Fund Store and Freightquote.com, Inc.
William "Bill" Grant III, Chief Operating Officer
William "Bill" Grant III has served as the Chief Operating Officer of SelectQuote since 2019. His previous roles at the company include Chief Marketing Officer and President of the Senior division from 2017 to 2019, and Senior Vice President of Marketing for the Senior division for five years prior to that.
Trevor Nohe, Chief Business Officer
Trevor Nohe has served as the Chief Business Officer at SelectQuote since 2022. Before joining SelectQuote in 2020, he was the CEO of Inside Response for five years and also served as CEO of Inside Academics. His background also includes experience as a management consultant for Deloitte Consulting and as a private equity investor at Five Elms Capital.
Daniel "Al" Boulware, General Counsel and Secretary
Daniel "Al" Boulware has served as SelectQuote's General Counsel and Secretary since 2019. Previously, he was the Vice President and General Counsel for SS&C Health, the healthcare segment of SS&C Technologies Holdings, Inc. He also worked as a Shareholder and an associate at Polsinelli, P.C.
AI Analysis | Feedback
The key risks to SelectQuote's business are:Legal and Regulatory Scrutiny
SelectQuote faces significant legal and regulatory challenges, notably a lawsuit filed by the U.S. Department of Justice (DOJ). The lawsuit alleges violations of the False Claims Act, accusing the company of receiving substantial illegal kickbacks from health insurers and steering Medicare beneficiaries toward plans that offered the highest commissions, rather than those best suited to the beneficiaries' needs. This has resulted in a notable drop in SelectQuote's stock price, the initiation of a securities class-action lawsuit, and concerns regarding potential fines, reputational damage, and operational disruptions.
High Debt Load and Financial Stability
The company exhibits a substantial reliance on debt financing, indicated by a debt-to-equity ratio of 2.27. This significant debt load raises concerns about SelectQuote's financial stability and its capacity to manage its obligations, particularly given its history of unprofitability.
Industry Headwinds, Competition, and Business Model Sustainability
SelectQuote is affected by broader industry challenges, including carrier plan changes that have negatively impacted policy retention and new customer acquisition. Insurance carriers are increasingly prioritizing their margins over policy growth, which directly diminishes SelectQuote's potential commission earnings. Furthermore, intense competition from direct-to-consumer digital platforms offered by insurers and pharmacies poses a threat to SelectQuote's market relevance and long-term revenue growth. The company also grapples with high customer acquisition costs and the risk of commoditization, which challenge its margin stability and growth. Despite experiencing revenue growth, SelectQuote has struggled with consistent profitability, reporting net losses in recent years, which leads to questions about the long-term sustainability of its business model.
AI Analysis | Feedback
Intensifying competition from insurance carriers directly investing in their own robust digital direct-to-consumer sales channels.
Evolving and stricter regulatory requirements for insurance sales, particularly within the Medicare market.
AI Analysis | Feedback
SelectQuote (SLQT) operates in several large addressable markets within the U.S. for its main products and services:
- The total addressable market for the insurance products SelectQuote distributes is estimated to be greater than $180 billion in the U.S.
- For healthcare services provided by its Population Health segment, the total addressable market in the U.S. is in excess of $1 trillion.
- The Senior segment, which focuses on products for Medicare beneficiaries, presents an annual commission revenue opportunity of approximately $30 billion in the U.S.
- The Life segment addresses a market with an annual commission revenue opportunity of approximately $105 billion in the U.S.
- The Auto & Home segments target markets with an estimated annual commission revenue opportunity of approximately $47 billion in the U.S.
- Within Population Health, the U.S. Pharmaceutical total addressable market is over $500 billion.
AI Analysis | Feedback
SelectQuote (SLQT) is anticipated to drive future revenue growth over the next 2-3 years through several key strategies and market dynamics:
- Growth in Healthcare Services and SelectRx: The company expects significant growth from its Healthcare Services segment, particularly through its SelectRx program. This program has shown success in improving medication adherence and reducing hospital days, contributing to strong revenue growth and membership increases. Despite some near-term challenges with drug reimbursement rates, SelectQuote remains confident in the long-term economics and expansion of this business.
- Expansion in the Life Insurance Business: SelectQuote's life insurance segment, encompassing term life and final expense policies, has consistently demonstrated revenue growth. The company continues to be pleased with the performance of this business, indicating it as a contributor to overall revenue expansion.
- Improved Agent Productivity and Efficiency via Technology and AI: SelectQuote is focused on leveraging technological advancements and artificial intelligence to enhance agent efficiency, reduce variable costs, and accelerate customer acquisition. This includes routing a significant number of calls through automation and powering healthcare services interactions with AI, which has led to reductions in agent enrollment time and health assessment time.
- Strategic Market Expansions and Product Diversification: The company aims to expand into underserved geographic markets and demographic segments. Furthermore, SelectQuote is diversifying its product offerings beyond traditional insurance into areas such as pharmacy, telehealth, and patient management to meet evolving consumer needs and capture new revenue streams.
- Sustained Performance in the Senior Segment (Medicare Advantage): While the senior segment experienced a decline in revenue in Q1 Fiscal Year 2026 due to changes in beneficiary eligibility requirements, SelectQuote has historically delivered robust results during the Annual Enrollment Period (AEP) with strong agent productivity and high close rates. The company continues to manage this segment to drive increasing cash flow and anticipates strong performance in upcoming enrollment seasons, leveraging its Medicare Advantage engine for growth when market conditions are favorable.
AI Analysis | Feedback
Share Repurchases
- SelectQuote did not repurchase any common stock during the fiscal year ended June 30, 2021.
Share Issuance
- In May 2020, SelectQuote completed its initial public offering (IPO), issuing 18,000,000 shares of common stock at $20.00 per share, raising approximately $360 million.
- In March 2021, selling stockholders conducted a secondary public offering of 10,600,000 shares at $27.50 per share, from which SelectQuote itself did not sell any shares or receive proceeds.
- The number of shares issued and outstanding increased from approximately 163.65 million as of August 2021 to around 175.95 million as of September 2025.
Inbound Investments
- In February/March 2025, SelectQuote closed a $350 million strategic investment from funds managed by Bain Capital, Morgan Stanley Private Credit, and Newlight Partners.
- The proceeds from this investment were intended to recapitalize the balance sheet, lower debt service, provide liquidity, and fund growth initiatives, with $260 million used to pay down an outstanding term loan.
- In October 2024, the company completed a $100 million Medicare Advantage commissions receivable securitization to improve capital flexibility and reduce its cost of capital.
Outbound Investments
- Information regarding significant outbound strategic investments or acquisitions by SelectQuote in other companies was not readily available within the provided search results for the specified period.
Capital Expenditures
- Capital expenditures were reported as $25 million for fiscal year 2022, $9.13 million for fiscal year 2023, and $11 million for fiscal year 2024.
- The company planned to use a portion of its IPO proceeds (May 2020) for capital expenditures, working capital, and general corporate purposes.
Latest Trefis Analyses
| Title | Date | |
|---|---|---|
| DASHBOARDS | ||
| SelectQuote Earnings Notes | 12/16/2025 | |
| null | 05/16/2025 | |
| SelectQuote (SLQT) Valuation Ratios Comparison | 05/15/2025 | |
| SelectQuote Total Shareholder Return (TSR): -13.8% in 2025 and -1.4% 3-yr compounded annual returns (below peer average) | 03/07/2025 |
| Title | |
|---|---|
| ARTICLES |
Trade Ideas
Select ideas related to SLQT.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 01302026 | FDS | FactSet Research Systems | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -19.1% | -19.1% | -23.8% |
| 01302026 | PFSI | PennyMac Financial Services | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | -7.6% | -7.6% | -9.2% |
| 01232026 | FIS | Fidelity National Information Services | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -22.6% | -22.6% | -22.6% |
| 01022026 | MORN | Morningstar | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | -23.9% | -23.9% | -26.8% |
| 01022026 | ABR | Arbor Realty Trust | Special | Short Squeeze PotentialShort Squeeze PotentialHas potential for a short squeeze. High short interest, rising short interest and high debt. | -2.9% | -2.9% | -6.7% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 8.01 |
| Mkt Cap | 0.3 |
| Rev LTM | 652 |
| Op Inc LTM | 50 |
| FCF LTM | -22 |
| FCF 3Y Avg | -24 |
| CFO LTM | -9 |
| CFO 3Y Avg | -12 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 25.2% |
| Rev Chg 3Y Avg | 21.4% |
| Rev Chg Q | 16.0% |
| QoQ Delta Rev Chg LTM | 4.2% |
| Op Mgn LTM | 6.0% |
| Op Mgn 3Y Avg | -0.5% |
| QoQ Delta Op Mgn LTM | 0.3% |
| CFO/Rev LTM | -1.6% |
| CFO/Rev 3Y Avg | -1.8% |
| FCF/Rev LTM | -3.8% |
| FCF/Rev 3Y Avg | -4.2% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 0.3 |
| P/S | 0.5 |
| P/EBIT | 1.0 |
| P/E | 1.5 |
| P/CFO | -1.6 |
| Total Yield | 11.8% |
| Dividend Yield | 0.0% |
| FCF Yield 3Y Avg | -8.8% |
| D/E | 1.0 |
| Net D/E | 0.1 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | -38.4% |
| 3M Rtn | -36.1% |
| 6M Rtn | -46.2% |
| 12M Rtn | -59.7% |
| 3Y Rtn | -34.2% |
| 1M Excs Rtn | -36.2% |
| 3M Excs Rtn | -41.9% |
| 6M Excs Rtn | -52.4% |
| 12M Excs Rtn | -71.3% |
| 3Y Excs Rtn | -103.2% |
Price Behavior
| Market Price | $0.84 | |
| Market Cap ($ Bil) | 0.2 | |
| First Trading Date | 05/21/2020 | |
| Distance from 52W High | -86.2% | |
| 50 Days | 200 Days | |
| DMA Price | $1.37 | $1.90 |
| DMA Trend | down | down |
| Distance from DMA | -39.0% | -56.0% |
| 3M | 1YR | |
| Volatility | 100.5% | 88.0% |
| Downside Capture | 588.98 | 308.92 |
| Upside Capture | 164.50 | 68.79 |
| Correlation (SPY) | 35.0% | 27.9% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 2.77 | 2.27 | 2.12 | 1.99 | 1.20 | 2.04 |
| Up Beta | -3.58 | -1.71 | -2.53 | 0.89 | 0.32 | 1.67 |
| Down Beta | 0.74 | 0.87 | 1.80 | 2.00 | 1.38 | 1.92 |
| Up Capture | 564% | 406% | 235% | 204% | 132% | 2309% |
| Bmk +ve Days | 11 | 22 | 34 | 71 | 142 | 430 |
| Stock +ve Days | 7 | 17 | 25 | 50 | 97 | 341 |
| Down Capture | 620% | 369% | 363% | 243% | 159% | 113% |
| Bmk -ve Days | 9 | 19 | 27 | 54 | 109 | 321 |
| Stock -ve Days | 12 | 21 | 33 | 66 | 141 | 373 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with SLQT | |
|---|---|---|---|---|
| SLQT | -85.8% | 87.8% | -1.84 | - |
| Sector ETF (XLF) | 2.0% | 19.4% | -0.02 | 32.1% |
| Equity (SPY) | 13.0% | 19.4% | 0.51 | 28.0% |
| Gold (GLD) | 67.2% | 25.5% | 1.99 | 7.4% |
| Commodities (DBC) | 5.2% | 16.8% | 0.13 | 10.2% |
| Real Estate (VNQ) | 7.8% | 16.6% | 0.28 | 19.2% |
| Bitcoin (BTCUSD) | -28.8% | 44.9% | -0.62 | 27.4% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with SLQT | |
|---|---|---|---|---|
| SLQT | -50.0% | 105.9% | -0.15 | - |
| Sector ETF (XLF) | 12.6% | 18.7% | 0.55 | 32.8% |
| Equity (SPY) | 13.3% | 17.0% | 0.62 | 34.9% |
| Gold (GLD) | 21.3% | 17.1% | 1.02 | 2.5% |
| Commodities (DBC) | 10.2% | 18.9% | 0.42 | 9.1% |
| Real Estate (VNQ) | 5.3% | 18.8% | 0.19 | 29.9% |
| Bitcoin (BTCUSD) | 8.2% | 57.2% | 0.36 | 17.8% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with SLQT | |
|---|---|---|---|---|
| SLQT | -29.3% | 100.9% | -0.12 | - |
| Sector ETF (XLF) | 14.2% | 22.2% | 0.59 | 29.4% |
| Equity (SPY) | 15.8% | 17.9% | 0.76 | 33.6% |
| Gold (GLD) | 14.8% | 15.6% | 0.79 | 2.7% |
| Commodities (DBC) | 8.0% | 17.6% | 0.37 | 9.1% |
| Real Estate (VNQ) | 6.8% | 20.7% | 0.29 | 28.3% |
| Bitcoin (BTCUSD) | 68.5% | 66.7% | 1.08 | 16.2% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 2/5/2026 | -29.0% | ||
| 11/6/2025 | -21.1% | -23.9% | -36.6% |
| 8/21/2025 | 41.5% | 31.7% | 12.0% |
| 5/12/2025 | -12.0% | -14.2% | -17.6% |
| 2/10/2025 | 30.8% | 38.1% | -17.4% |
| 9/13/2024 | -43.7% | -44.3% | -37.6% |
| 5/9/2024 | 3.6% | 17.6% | 13.2% |
| 2/7/2024 | 0.9% | 34.2% | 58.6% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 8 | 8 | 7 |
| # Negative | 11 | 10 | 11 |
| Median Positive | 10.8% | 24.6% | 13.2% |
| Median Negative | -21.1% | -23.3% | -24.9% |
| Max Positive | 41.5% | 38.1% | 58.6% |
| Max Negative | -47.3% | -56.8% | -59.6% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 12/31/2025 | 02/05/2026 | 10-Q |
| 09/30/2025 | 11/06/2025 | 10-Q |
| 06/30/2025 | 08/21/2025 | 10-K |
| 03/31/2025 | 05/12/2025 | 10-Q |
| 12/31/2024 | 02/10/2025 | 10-Q |
| 09/30/2024 | 11/04/2024 | 10-Q |
| 06/30/2024 | 09/13/2024 | 10-K |
| 03/31/2024 | 05/09/2024 | 10-Q |
| 12/31/2023 | 02/08/2024 | 10-Q |
| 09/30/2023 | 11/03/2023 | 10-Q |
| 06/30/2023 | 09/13/2023 | 10-K |
| 03/31/2023 | 05/10/2023 | 10-Q |
| 12/31/2022 | 02/07/2023 | 10-Q |
| 09/30/2022 | 11/03/2022 | 10-Q |
| 06/30/2022 | 08/29/2022 | 10-K |
| 03/31/2022 | 05/05/2022 | 10-Q |
Industry Resources
| Financials Resources |
| Federal Reserve Economic Data |
| Federal Reserve |
| FDIC Data |
| American Banker |
| The Banker |
| Banking Technology |
| Insurance Brokers Resources |
| Insurance Business America |
| A.M. Best |
| National Underwriter |
| Insurance News |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.